ACADIA Pharmaceuticals Funding & Investors
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
acadia-pharm.comTotal Amount Raised: $121,600,000
ACADIA Pharmaceuticals Funding Rounds
Post Ipo Equity
$20,000,000
Post Ipo Equity Investors
Nomura InternationalOxford Bioscience PartnersPost Ipo Equity
$10,000,000
Post Ipo Equity Investors
Oxford Bioscience PartnersSeries F
$25,000,000
Series F Investors
Oxford Bioscience PartnersOrbiMedLD PensionsHambrecht & Quist Capital ManagementABN AMRO FundFederated InvestorsForbionDebt Financing
$22,000,000
Debt Financing Investors
H&Q Healthcare InvestorsKAUFMANN FUNDDKA CapitalPacific Rim VenturesOrbiMedSeries D
$10,700,000
Series D Investors
LD PensionsDKA CapitalSeries B
$3,000,000
Series B Investors
BankInvestLD PensionsDKA CapitalDebt Financing
$7,500,000
Debt Financing Investors
VækstfondenSeries A
$6,000,000
Series A Investors
BankInvestLD PensionsDKA CapitalGrant
$2,400,000
Grant Investors
NINDSPost Ipo Equity
$15,000,000
Post Ipo Equity Investors
VenrockNew Enterprise Associates (NEA)
Funding info provided by Diffbot.